Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nafamostat Mesilate in CRRT for High Bleeding Risk Patients
NCT02478242Phase 4Completed
- Sponsor
- Kyungpook National University Hospital
- Start
- Jul 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Nafabelltan in acute kidney injury (AKI), sponsored by Kyungpook National University Hospital. Started Jul 2010; status: completed.
02
Drugs
Nafabelltan
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02478242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478242.